Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JBS N.V. Class A Common Shares (JBS) vs Tenet Healthcare Corporation (THC) Price & Performance

JBS N.V. Class A Common SharesTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

JBS N.V. Class A Common Shares vs Tenet Healthcare Corporation — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.86B), while Tenet Healthcare Corporation trades at $271.76 (market cap $21.49B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and JBS N.V. Class A Common Shares pays a 10.38% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and Tenet Healthcare Corporation for 16 Days on average.

JBSTHC
Market Cap
$13.86B$21.49B
Volume
4,980,049599,998
Sector
Consumer StaplesHealth
52-Week High
$18.42$280.77
52-Week Low
$10.86$161.37
Typical Hold Time
0 Days16 Days
Enterprise Value
$34.83B$32.57B
Dividend Yield
10.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JBS N.V. Class A Common Shares

JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.

The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $266.91, down 0.69% today but maintains strong technical momentum with bullish moving averages. The company demonstrates robust fundamentals with three consecutive quarterly earnings beats and impressive profitability metrics including 82.83% gross margins and 53.31% ROE. Recent news highlights continued investor interest and upcoming Q3 2026 earnings release on October 29.

THC presents a compelling investment case with attractive valuation (P/E 10.32), strong analyst support (81% buy rating), and 6.2% upside to consensus target of $283.36. Key risks include cash flow sustainability for capital return strategy and potential surgical volume pressures. The stock's combination of value pricing and growth execution supports continued upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JBS
100% Buy0% Sell
Avg holding period · 0 Days
THC

No sentiment data available yet.

About JBS N.V. Class A Common Shares

JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.

Read more on JBS →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →